New Ray Medicine International Holding Limited (HKG:6108)

Hong Kong · Delayed Price · Currency is HKD

0.2020

+0.0010 (0.50%)

Jun 18, 2026, 10:59 AM HKT

Revenue by Segment

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Provision of Marketing and Promotion Services of Drugs	2.44M	5.24M	7.30M	6.02M	5.76M
Provision of Marketing and Promotion Services of Drugs Growth	-53.41%	-28.28%	21.36%	4.48%	27.41%
Distribution and Trading of Pharmaceutical Products	127.93M	88.71M	42.85M	83.75M	329.62M
Distribution and Trading of Pharmaceutical Products Growth	44.22%	107.01%	-48.84%	-74.59%	156.13%
Total	130.37M	93.95M	50.15M	89.77M	335.38M
Total Growth	38.78%	87.31%	-44.13%	-73.23%	151.76%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
People's Republic of China (PRC)	130.37M	93.95M	50.15M	89.77M	335.38M
People's Republic of China (PRC) Growth	38.78%	87.31%	-44.13%	-73.23%	151.76%
Total	130.37M	93.95M	50.15M	89.77M	335.38M
Total Growth	38.78%	87.31%	-44.13%	-73.23%	151.76%